Ardelyx
ARDX
88 hedge funds and large institutions have $190M invested in Ardelyx in 2017 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 34 increasing their positions, 15 reducing their positions, and 16 closing their positions.
127% more repeat investments, than reductions
Existing positions increased: 34 | Existing positions reduced: 15
50% more first-time investments, than exits
New positions opened: 24 | Existing positions closed: 16
10% more funds holding
Funds holding: 80 → 88 (+8)
2.96% less ownership
Funds ownership: 81.63% → 78.66% (-3%)
61% less capital invested
Capital invested by funds: $489M → $190M (-$299M)
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
99% less call options, than puts
Call options by funds: $1K | Put options by funds: $141K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
+$12.2M |
| 2 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$4.64M |
| 3 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
+$2.12M |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$1.62M |
| 5 |
CM
Crestline Management
Fort Worth,
Texas
|
+$1.31M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$14M |
| 2 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$10.5M |
| 3 |
First Manhattan
New York
|
-$5.25M |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
-$4.66M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$4.46M |
ARDX Hedge Fund Activity: Q2 2017 in Review
88 of the 4,022 institutional investors tracked by Wall St. Rank reported a position in Ardelyx (ARDX) for Q2 2017, worth a combined $190M — down 61% from $489M a quarter earlier.
Buyers outnumbered sellers: 24 funds opened new ARDX positions and 16 closed out — a net gain of 8 holders — while 34 added to existing stakes and 15 trimmed.
The largest buyer was Deerfield Management, adding an estimated $12.2M. The largest seller was PFM Health Sciences, exiting entirely with an estimated $14M sold.
- 88 institutional investors held Ardelyx (ARDX) as of Q2 2017, up from 80 in Q1 2017.
- Funds reported $190M of Ardelyx stock for Q2 2017, down 61% quarter-over-quarter.
- 24 funds opened new Ardelyx positions in Q2 2017 and 16 closed out, a net change of +8 holders.
- The largest Ardelyx buyer in Q2 2017 was Deerfield Management, an estimated $12.2M added.
- The largest Ardelyx seller in Q2 2017 was PFM Health Sciences, an estimated $14M sold.
Based on aggregated 13F filings for Q2 2017.